PHARMACOKINETICS OF THE PROTON PUMP INHIBITOR PANTOPRAZOLE IN PATIENTS WITH SEVERE RENAL IMPAIRMENT

被引：0
|
作者：
LINS, RL
DECLERCQ, I
HARTMANN, M
HUBER, R
BLIESATH, H
LUHMANN, R
WURST, W
机构：
[1] AZ STUIVENBURG,RES UNIT,ANTWERP,BELGIUM
[2] BYK GULDEN LOMBERG GMBH,CONSTANCE,GERMANY
来源：
GASTROENTEROLOGY | 1994年 / 106卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A126 / A126
页数：1
相关论文
共 50 条
  • [21] Pantoprazole - A new benzimidazole proton pump inhibitor for oval and IV administration
    Smith, C
    FORMULARY, 2000, 35 (01) : 28 - +
  • [22] Pantoprazole, a proton pump inhibitor, increases orthodontic tooth movement in rats
    Shirazi, Mohsen
    Alimoradi, Houman
    Kheirandish, Yasaman
    Etemad-Moghadam, Shahroo
    Alaeddini, Mojgan
    Meysamie, Alipasha
    Meybodi, Seyed Amir Reza Fatathi
    Dehpour, Ahmad Reza
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2014, 17 (06) : 448 - 453
  • [23] Pantoprazole: A new proton pump inhibitor in the management of upper gastrointestinal disease
    Bardhan, KD
    DRUGS OF TODAY, 1999, 35 (10) : 773 - 808
  • [24] Pharmacokinetics and effect an caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole
    Andersson, T
    Holmberg, J
    Röhss, K
    Walan, A
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (04) : 369 - 375
  • [25] Pharmacokinetics of pantoprazole in patients with moderate and severe hepatic dysfunction
    Ferron, GM
    Preston, RA
    Noveck, RJ
    Pockros, P
    Mayer, P
    Getsy, J
    Turner, M
    Abell, M
    Paul, J
    CLINICAL THERAPEUTICS, 2001, 23 (08) : 1180 - 1192
  • [26] Proton-pump inhibitor use amongst patients with severe hypomagnesemia
    Seah, Sherry
    Tan, Yen Kheng
    Teh, Kevin
    Loh, Wann Jia
    Tan, Pei Ting
    Goh, Leng Chuan
    Malakar, Roy Debajyoti
    Aw, Tar Choon
    Lau, Chin Shern
    Dhalliwal, Trishpal
    Kui, Swee Leng
    Kam, Jia Wen
    Khoo, Joan
    Tay, Tunn Lin
    Tan, Eberta
    Au, Vanessa
    Soh, Shui Boon
    Zhang, Meifen
    King, Thomas F.
    Gani, Linsey
    Puar, Troy H.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [27] Population Pharmacokinetics and Therapeutic Efficacy of Febuxostat in Patients with Severe Renal Impairment
    Hira, Daiki
    Chisaki, Yugo
    Noda, Satoshi
    Araki, Hisazumi
    Uzu, Takashi
    Maegawa, Hiroshi
    Yano, Yoshitaka
    Morita, Shin-ya
    Terada, Tomohiro
    PHARMACOLOGY, 2015, 96 (1-2) : 90 - 98
  • [28] Pharmacokinetics of single-dose morinidazole in patients with severe renal impairment
    Zhang, Hao
    Huang, Lu
    Huang, Yuan-yuan
    Yi, Bin
    Pei, Qi
    Tan, Hong-yi
    Huang, Jie
    Liu, Ji-shi
    Yuan, Hong
    Yang, Guo-ping
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (02) : 159 - 165
  • [29] Synthesis and Characterization of Two Impurities in (S)-Pantoprazole as a Chiral Proton Pump Inhibitor
    Ke, Jia
    Deng, Xin-Shan
    Li, Jin-Long
    Li, Yong-Peng
    Niu, Yuan-Yuan
    Wang, Shao-Li
    Liu, Xiao-Ping
    Hu, Chun
    LATIN AMERICAN JOURNAL OF PHARMACY, 2018, 37 (08): : 1668 - 1671
  • [30] Effect of Proton Pump Inhibitor Pantoprazole on Growth and Morphology of Oral Lactobacillus Strains
    Altman, Kenneth W.
    Chhaya, Vina
    Hammer, Neal D.
    Pavlova, Sylvia
    Vesper, Benjamin J.
    Tao, Lin
    Radosevich, James A.
    LARYNGOSCOPE, 2008, 118 (04): : 599 - 604
12345